We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
(-8.2%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$934K |
| 2 |
MASI
Masimo
MASI
|
+$931K |
| 3 |
Palladyne AI
PDYN
|
+$929K |
| 4 |
Equity Lifestyle Properties
ELS
|
+$926K |
| 5 |
BorgWarner
BWA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlyle Group
CG
|
+$962K |
| 2 |
GeneDx Holdings
WGS
|
+$933K |
| 3 |
Viasat
VSAT
|
+$852K |
| 4 |
INFA
Informatica
INFA
|
+$807K |
| 5 |
Amgen
AMGN
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.61% |
| 2 | Technology | 17.16% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 11.59% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Protolabs
PRLB
$1.86B
| – | – |
-6,625
| Closed | -$259K |
|
902
PTC
PTC
$13.7B
| – | – |
-1,093
| Closed | -$201K |
|
903
Portillo's
PTLO
$315M
| – | – |
-62,236
| Closed | -$585K |
|
904
PubMatic
PUBM
$581M
| – | – |
-14,341
| Closed | -$211K |
|
905
ProPetro Holding
PUMP
$1.45B
| – | – |
-34,510
| Closed | -$322K |
|
906
Papa John's
PZZA
$999M
| – | – |
-7,792
| Closed | -$320K |
|
907
Qualcomm
QCOM
$176B
| – | – |
-2,147
| Closed | -$330K |
|
908
Qorvo
QRVO
$7.63B
| – | – |
-4,088
| Closed | -$286K |
|
909
QuantumScape Corp
QS
$3B
| – | – |
-52,648
| Closed | -$273K |
|
910
Roblox
RBLX
$34B
| – | – |
-8,700
| Closed | -$503K |
|
|
RDFN
911
DELISTED
Redfin
RDFN
| – | – |
-12,614
| Closed | -$99.3K |
|
912
Regenxbio
RGNX
$623M
| – | – |
-12,538
| Closed | -$96.9K |
|
913
Ryman Hospitality Properties
RHP
$8.4B
| – | – |
-2,679
| Closed | -$280K |
|
914
ResMed
RMD
$28.3B
| – | – |
-1,518
| Closed | -$347K |
|
915
RenaissanceRe
RNR
$13.7B
| – | – |
-966
| Closed | -$240K |
|
916
Gibraltar Industries
ROCK
$1.34B
| – | – |
-11,037
| Closed | -$650K |
|
917
Rollins
ROL
$18.6B
| – | – |
-5,377
| Closed | -$249K |
|
918
RPM International
RPM
$13.7B
| – | – |
-2,295
| Closed | -$282K |
|
919
Rayonier Advanced Materials
RYAM
$565M
| – | – |
-17,425
| Closed | -$144K |
|
920
Safety Insurance
SAFT
$1.52B
| – | – |
-3,687
| Closed | -$304K |
|
921
Saic
SAIC
$5.03B
| – | – |
-2,076
| Closed | -$232K |
|
922
Sanmina
SANM
$11.2B
| – | – |
-2,945
| Closed | -$223K |
|
923
SAP
SAP
$187B
| – | – |
-937
| Closed | -$231K |
|
924
Southern Copper
SCCO
$141B
| – | – |
-4,431
| Closed | -$383K |
|
925
Vivid Seats
SEAT
$77M
| – | – |
-5,799
| Closed | -$537K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2025 Portfolio in Review
As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
- EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
- EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
- EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
- EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
- EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
- EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.